Investor Presentation June 2021
Quarter Ended Mar 31, 2021
Total revenue of $176.1 million, up 7% from $165.1 million for the prior-year quarter.
Net income increased to $14.5 million, from $3.0 million for the prior-year quarter.
Net income attributable to ApolloMed increased to $13.2 million, from $4.1 million for the prior-year quarter.
Source: Q1 2021 Press Release
For complete information regarding our financials, see our periodic filings
ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high-quality care to patients in a cost-effective manner.